资源有限国家的癌症护理:约旦作为一个例子
Hikmat Abdel-Razeq1,2, Akram Al-Ibraheem2,3, Kamal Al-Rabi1,2
1Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
JCO global oncology
|October 3, 2024
概括
在约旦,癌症越来越令人担忧,发病率不断增加,但死亡率高于西方国家. 迫切需要国家癌症控制计划,以便早期检测,经济有效的治疗和全面的护理.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
背景情况:
- 癌症是约旦第二大死亡原因,是一个日益严重的健康挑战.
- 约旦国家癌症登记处面临报告滞后,缺少结果数据和分期准确性等问题.
- 由于人口增长,人口老龄化,肥胖,吸烟和缺乏运动,癌症发病率正在上升,尽管年龄标准化率低于西方国家.
研究的目的:
- 分析约旦目前的癌症情况.
- 突出癌症诊断,治疗和护理方面的挑战.
- 倡导一个全面的国家癌症控制计划.
主要方法:
- 审查国家癌症注册数据和健康统计数据.
- 对癌症发病率和死亡率趋势的分析.
- 评估现有的癌症查和遗传学计划.
主要成果:
- 癌症在晚期和年轻时被诊断为癌症,尽管像约旦乳腺癌计划这样的机会性查成功.
- 与西方社会相比,年龄标准化癌症发病率较低,但死亡率较高.
- 在建立区域临床癌症遗传学计划方面取得了重大进展.
结论:
- 约旦面临着不断上升的癌症护理成本,需要创新解决方案,如改善临床试验准入和门诊护理.
- 一个全面的国家癌症控制战略是一个紧急的优先事项,包括查,早期检测,经济有效的治疗,息护理和生存率.
- 扩大全民医疗覆盖率对于平等获得癌症护理各方面的服务至关重要.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


